American National Bank & Trust’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-800
Closed -$27K 610
2022
Q2
$27K Hold
800
0.01% 223
2022
Q1
$58K Hold
800
0.01% 176
2021
Q4
$73K Hold
800
0.01% 164
2021
Q3
$101K Hold
800
0.02% 126
2021
Q2
$133K Hold
800
0.03% 123
2021
Q1
$145K Hold
800
0.03% 112
2020
Q4
$160K Hold
800
0.04% 102
2020
Q3
$175K Hold
800
0.05% 95
2020
Q2
$153K Hold
800
0.05% 95
2020
Q1
$124K Hold
800
0.05% 99
2019
Q4
$67K Hold
800
0.02% 116
2019
Q3
$54K Buy
+800
New +$52.7K 0.02% 125

Other funds holding TDOC

American National Bank & Trust's TDOC Position: Q3 2022 in Review

American National Bank & Trust sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 800 shares — an estimated $27K sold.

American National Bank & Trust first reported a position in TDOC in Q3 2019 and held it in 12 quarters. The position peaked at $175K in Q3 2020. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • American National Bank & Trust reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • American National Bank & Trust sold 800 Teladoc Health shares in Q3 2022, an estimated $27K.
  • American National Bank & Trust first reported a position in Teladoc Health in Q3 2019 and held it in 12 quarters.
  • American National Bank & Trust's Teladoc Health position peaked at $175K in Q3 2020.
  • 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on American National Bank & Trust's 13F filing for Q3 2022, filed 5 Oct 2022.